Our previous work identified increased CTLA‐4 expression in joint‐localized dendritic cells and CD4+ T cells following nanoparticle treatment, which was associated with reduced arthritis severity and protection against bone and cartilage damage.37 The gene discussed is CTLA4; the disease is arthritic joint disease.